A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF

Background. The development of new methods for delivering biologically active substances to the surgical site is a promising area of modern surgery. One of the biologically active substances used to stimulate regeneration is the vascular endothelial growth factor (VEGF). The search for ways to gradu...

Full description

Bibliographic Details
Main Author: I. S. Kurganskiy
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2021-01-01
Series:Acta Biomedica Scientifica
Subjects:
Online Access:https://www.actabiomedica.ru/jour/article/view/2530
_version_ 1797237233618518016
author I. S. Kurganskiy
author_facet I. S. Kurganskiy
author_sort I. S. Kurganskiy
collection DOAJ
description Background. The development of new methods for delivering biologically active substances to the surgical site is a promising area of modern surgery. One of the biologically active substances used to stimulate regeneration is the vascular endothelial growth factor (VEGF). The search for ways to gradually and over a long period of time deliver VEGF to the surgical site is a promising area of research.Aim. To develop a method for delivering VEGF to the surgical site and to assess its elimination in the early postoperative period.Materials and methods. The study included 78 male Wistar rats at the age of 10 months. All animals underwent reconstructive surgery on the trachea, the animals were divided into 3 groups: group 1 – without a medicinal film, group 2 – with a medicinal film of prolonged action, group 3 – with a medicinal film of prolonged action containing VEGF. Blood sampling was carried out on days 1, 3, and 21 of the study, using the method of enzyme-linked immunosorbent assay to determine the level of VEGF in blood plasma, the unit of measurement was pg/ml.Results. A long-acting medicinal film containing VEGF has been developed. It was revealed that the use of a medicinal film containing VEGF significantly increases the VEGF index in blood plasma by 26 times starting from the first day of the study and remained high throughout the study.Conclusion. The results obtained indicate the effectiveness of the developed medicinal film of prolonged  action. Elimination of VEGF starts from the first day of the study and lasts up to 21 days. High VEGF indices,  according to the authors, are associated with the exogenous introduction of VEGF into the animal organism in the form of a prolonged-action film and the induction of endogenous VEGF in rats.
first_indexed 2024-03-08T12:16:27Z
format Article
id doaj.art-ddd6fd459cd44acba425b6f8c3ba4e7d
institution Directory Open Access Journal
issn 2541-9420
2587-9596
language Russian
last_indexed 2024-04-24T17:16:30Z
publishDate 2021-01-01
publisher Scientific Сentre for Family Health and Human Reproduction Problems
record_format Article
series Acta Biomedica Scientifica
spelling doaj.art-ddd6fd459cd44acba425b6f8c3ba4e7d2024-03-28T07:49:24ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962021-01-015628228510.29413/ABS.2020-5.6.382106A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGFI. S. Kurganskiy0Irkutsk Scientific Centre of Surgery and TraumatologyBackground. The development of new methods for delivering biologically active substances to the surgical site is a promising area of modern surgery. One of the biologically active substances used to stimulate regeneration is the vascular endothelial growth factor (VEGF). The search for ways to gradually and over a long period of time deliver VEGF to the surgical site is a promising area of research.Aim. To develop a method for delivering VEGF to the surgical site and to assess its elimination in the early postoperative period.Materials and methods. The study included 78 male Wistar rats at the age of 10 months. All animals underwent reconstructive surgery on the trachea, the animals were divided into 3 groups: group 1 – without a medicinal film, group 2 – with a medicinal film of prolonged action, group 3 – with a medicinal film of prolonged action containing VEGF. Blood sampling was carried out on days 1, 3, and 21 of the study, using the method of enzyme-linked immunosorbent assay to determine the level of VEGF in blood plasma, the unit of measurement was pg/ml.Results. A long-acting medicinal film containing VEGF has been developed. It was revealed that the use of a medicinal film containing VEGF significantly increases the VEGF index in blood plasma by 26 times starting from the first day of the study and remained high throughout the study.Conclusion. The results obtained indicate the effectiveness of the developed medicinal film of prolonged  action. Elimination of VEGF starts from the first day of the study and lasts up to 21 days. High VEGF indices,  according to the authors, are associated with the exogenous introduction of VEGF into the animal organism in the form of a prolonged-action film and the induction of endogenous VEGF in rats.https://www.actabiomedica.ru/jour/article/view/2530tracheamedicinal filmvegfexperimentrat
spellingShingle I. S. Kurganskiy
A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
Acta Biomedica Scientifica
trachea
medicinal film
vegf
experiment
rat
title A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_full A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_fullStr A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_full_unstemmed A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_short A Method of Manufacturing a Long-Acting Medicinal Film Containing VEGF
title_sort method of manufacturing a long acting medicinal film containing vegf
topic trachea
medicinal film
vegf
experiment
rat
url https://www.actabiomedica.ru/jour/article/view/2530
work_keys_str_mv AT iskurganskiy amethodofmanufacturingalongactingmedicinalfilmcontainingvegf
AT iskurganskiy methodofmanufacturingalongactingmedicinalfilmcontainingvegf